Keywords: abpi, welcomes, nice, decision, xenical, national, institute

ABPI welcomes NICE decision on Xenical

Article | 13 March 2001

The National Institute for Clinical Excellence's decision to permitRoche's anti-obesity drug Xenical (orlistat) to remain prescribable on the National Health ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

orlistat

Xenical

Go to drug listing